• Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=32144432; PubMed=34275013).
  

PubMed=32144432; DOI=10.1007/s00280-020-04045-9
Goto H., Yoshino Y., Ito M., Nagai J.-i., Kumamoto T., Inukai T., Sakurai Y., Miyagawa N., Keino D., Yokosuka T., Iwasaki F., Hamanoue S., Shiomi M., Goto S.
Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.
Cancer Chemother. Pharmacol. 85:773-783(2020)

PubMed=34275013; DOI=10.1007/s00280-021-04321-2
Goto H., Yoshino Y., Ito M., Nagai J.-i., Kumamoto T., Inukai T., Sakurai Y., Miyagawa N., Keino D., Yokosuka T., Iwasaki F., Hamanoue S., Shiomi M., Goto S.
Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.
Cancer Chemother. Pharmacol. 88:1055-1056(2021)

PubMed=35124168; DOI=10.1016/j.jsbmb.2022.106068
Tamai M., Kasai S., Akahane K., Thu T.N., Kagami K., Komatsu C., Abe M., Watanabe A., Goi K., Miyake K., Inaba T., Takita J., Goto H., Minegishi M., Iwamoto S., Sugita K., Inukai T.
Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
J. Steroid Biochem. Mol. Biol. 218:106068.1-106068.12(2022)